Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Summit reports results from phase Ib study of SMT-C1100 in pediatric DMD patients

May 22, 2014

Japanese orphan drug designation for Edison's EPI-743 in Leigh syndrome

May 22, 2014

Pharmaleads patents new mixed NEP/AP-N inhibitors

May 22, 2014

Bioequivalence study begins for Elite Pharmaceuticals' third opioid abuse deterrent drug

May 22, 2014

Synthetic MTDL as a novel therapeutic for ischemic stroke

May 22, 2014

Vertex designs selective HSP inhibitors for neurodegenerative disorders

May 22, 2014

Dainippon Sumitomo Pharma synthesizes new mGlu5 receptor modulators

May 21, 2014

KineMed and CHDI Foundation expand Huntington's disease collaboration

May 21, 2014

Takeda Pharmaceutical discloses new CH24H inhibitors

May 21, 2014

Merck & Co. synthesizes novel sodium channel blockers

May 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...